Enzo Biochem Price to Sales Ratio 2010-2022 | ENZ
Historical PS ratio values for Enzo Biochem (ENZ) over the last 10 years. The current P/S ratio for Enzo Biochem as of January 27, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Enzo Biochem P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-01-27 |
1.41 |
|
0.69 |
| 2022-10-31 |
2.14 |
$2.03 |
1.05 |
| 2022-07-31 |
2.37 |
$2.21 |
1.07 |
| 2022-04-30 |
2.55 |
$2.30 |
1.11 |
| 2022-01-31 |
3.22 |
$2.44 |
1.32 |
| 2021-10-31 |
3.44 |
$2.39 |
1.44 |
| 2021-07-31 |
3.26 |
$2.44 |
1.34 |
| 2021-04-30 |
3.07 |
$2.33 |
1.31 |
| 2021-01-31 |
2.82 |
$2.02 |
1.40 |
| 2020-10-31 |
1.82 |
$1.77 |
1.03 |
| 2020-07-31 |
2.38 |
$1.60 |
1.49 |
| 2020-04-30 |
3.02 |
$1.63 |
1.86 |
| 2020-01-31 |
2.51 |
$1.69 |
1.49 |
| 2019-10-31 |
3.16 |
$1.69 |
1.87 |
| 2019-07-31 |
3.91 |
$1.71 |
2.28 |
| 2019-04-30 |
3.47 |
$1.76 |
1.97 |
| 2019-01-31 |
3.76 |
$1.88 |
2.00 |
| 2018-10-31 |
3.32 |
$2.03 |
1.64 |
| 2018-07-31 |
4.42 |
$2.15 |
2.06 |
| 2018-04-30 |
6.00 |
$2.22 |
2.71 |
| 2018-01-31 |
7.36 |
$2.26 |
3.25 |
| 2017-10-31 |
9.85 |
$2.27 |
4.33 |
| 2017-07-31 |
10.85 |
$2.27 |
4.78 |
| 2017-04-30 |
8.80 |
$2.29 |
3.84 |
| 2017-01-31 |
6.68 |
$2.28 |
2.93 |
| 2016-10-31 |
6.10 |
$2.24 |
2.72 |
| 2016-07-31 |
6.97 |
$2.22 |
3.15 |
| 2016-04-30 |
4.98 |
$2.21 |
2.25 |
| 2016-01-31 |
4.74 |
$2.16 |
2.19 |
| 2015-10-31 |
3.72 |
$2.15 |
1.73 |
| 2015-07-31 |
3.00 |
$2.16 |
1.39 |
| 2015-04-30 |
2.80 |
$2.18 |
1.28 |
| 2015-01-31 |
3.15 |
$2.21 |
1.43 |
| 2014-10-31 |
5.22 |
$2.24 |
2.33 |
| 2014-07-31 |
4.80 |
$2.27 |
2.11 |
| 2014-04-30 |
4.20 |
$2.28 |
1.84 |
| 2014-01-31 |
2.81 |
$2.29 |
1.22 |
| 2013-10-31 |
2.49 |
$2.31 |
1.08 |
| 2013-07-31 |
2.18 |
$2.38 |
0.92 |
| 2013-04-30 |
2.24 |
$2.47 |
0.91 |
| 2013-01-31 |
2.89 |
$2.57 |
1.13 |
| 2012-10-31 |
2.00 |
$2.65 |
0.76 |
| 2012-07-31 |
1.50 |
$2.66 |
0.56 |
| 2012-04-30 |
2.74 |
$2.68 |
1.02 |
| 2012-01-31 |
2.55 |
$2.68 |
0.95 |
| 2011-10-31 |
2.86 |
$2.66 |
1.08 |
| 2011-07-31 |
3.84 |
$2.66 |
1.44 |
| 2011-04-30 |
3.99 |
$2.62 |
1.52 |
| 2011-01-31 |
4.96 |
$2.57 |
1.93 |
| 2010-10-31 |
4.31 |
$2.56 |
1.68 |
| 2010-07-31 |
4.60 |
$2.56 |
1.80 |
| 2010-04-30 |
5.97 |
$2.55 |
2.34 |
| 2010-01-31 |
4.74 |
$2.55 |
1.86 |
| 2009-10-31 |
5.51 |
$2.49 |
2.21 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.073B |
$0.107B |
|
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
|
